Prevention of heart failure progression: current approaches

Area of Science:

• Cardiology
• Pathophysiology
• Pharmacology

Background:

• Heart failure arises from myocardial damage and stress, regardless of the cause.
• Compensatory mechanisms, including the sympathetic nervous system and renin-angiotensin-aldosterone system, initially manage cardiac overload but can lead to myocyte dysfunction and fibrosis.
• Progressive cell death and fibrous tissue replacement characterize advanced heart failure.

Purpose of the Study:

• To outline the pathophysiology of heart failure.
• To discuss current therapeutic strategies for managing heart failure.
• To highlight the potential of complete neurohormonal blockade as a future therapeutic goal.

Main Methods:

• Review of existing literature on heart failure mechanisms and treatments.
• Analysis of the roles of neurohormonal systems in cardiac remodeling.
• Discussion of pharmacological interventions, including diuretics, vasodilators, and adrenergic blockade.

Main Results:

• Compensatory mechanisms in heart failure can paradoxically promote disease progression.
• Current therapies focus on reducing cardiac workload and mitigating adverse neurohormonal effects.
• Complete blockade of detrimental neurohormonal pathways is a promising therapeutic objective.

Conclusions:

• Effective heart failure management requires reducing cardiac loading and avoiding therapies that exacerbate the condition.
• Targeting neurohormonal pathways involved in adverse cardiac remodeling is crucial for improving prognosis.
• Ongoing clinical trials are essential to establish definitive treatment protocols for preventing heart failure progression.